Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ludwig, M.
Right arrow Articles by Diedrich, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ludwig, M.
Right arrow Articles by Diedrich, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 10, 2437-2441, October 1999
© 1999 European Society of Human Reproduction and Embryology

Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration

M. Ludwig1,3, W. Jelkmann2, O. Bauer1 and K. Diedrich1

1 Department of Gynecology and Obstetrics and 2 Institute of Physiology, Medical University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany

In this prospective study the concentration of circulating vascular endothelial growth factor (VEGF) was followed in 10 patients with severe ovarian hyperstimulation syndrome (OHSS) after ovarian stimulation and in 15 patients without OHSS. VEGF was assayed by means of two different commercially available kits as either free or total VEGF in serum. The concentration of free VEGF was significantly higher on the days of human chorionic gonadotrophin (HCG) administration (309.4 ± 165.0 versus 190.3 ± 127.8 pg/ml, P < 0.05) and embryo transfer (315.0 ± 125.2 versus 209.3 ± 137.2 pg/ml, P < 0.05) in the OHSS compared to the control group. No such difference existed with respect to total circulating VEGF. In addition, there was no significant rise in the free or in the total serum VEGF concentration in the OHSS patients or the controls from the day of HCG administration up to the days of oocyte retrieval or embryo transfer. A cut-off concentration of 200 pg/ml free serum VEGF concentration on the day of HCG treatment resulted in a sensitivity of 90% and a specificity of 80% for the prediction of OHSS development. This is the first report on the parallel measurement of free and total VEGF in serum following ovarian stimulation. The value of the proposed cut-off concentration should be confirmed in a study of a larger group of women.

Key words: OHSS/ovarian stimulation/pregnancy/VEGF

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
M. Julio-Pieper, P. Lozada, V. Tapia, M. Vega, C. Miranda, D. Vantman, S. R. Ojeda, and C. Romero
Nerve Growth Factor Induces Vascular Endothelial Growth Factor Expression in Granulosa Cells via a trkA Receptor/Mitogen-Activated Protein Kinase-Extracellularly Regulated Kinase 2-Dependent Pathway
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3065 - 3071.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
S. R. Soares, R. Gomez, C. Simon, J. A. Garcia-Velasco, and A. Pellicer
Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome
Hum. Reprod. Update, April 2, 2008; (2008) dmn008v1.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
B.C.J.M. Fauser, K. Diedrich, P. Devroey, and on behalf of the Evian Annual Reproduction (EVAR)
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation
Hum. Reprod. Update, January 1, 2008; 14(1): 1 - 14.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. Manau, F. Fabregues, J. Penarrubia, M. Creus, F. Carmona, G. Casals, W. Jimenez, and J. Balasch
Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF
Hum. Reprod., March 1, 2007; 22(3): 669 - 675.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
Y. Kodama, Y. Kitta, T. Nakamura, H. Takano, K. Umetani, D. Fujioka, Y. Saito, K.-i. Kawabata, J.-e. Obata, A. Mende, et al.
Atorvastatin Increases Plasma Soluble Fms-Like Tyrosine Kinase-1 and Decreases Vascular Endothelial Growth Factor and Placental Growth Factor in Association With Improvement of Ventricular Function in Acute Myocardial Infarction
J. Am. Coll. Cardiol., July 4, 2006; 48(1): 43 - 50.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. Pau, I. Alonso-Muriel, R. Gomez, E. Novella, A. Ruiz, J. A. Garcia-Velasco, C. Simon, and A. Pellicer
Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome
Hum. Reprod., June 1, 2006; 21(6): 1453 - 1460.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Babayof, E. J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, M. Gal, B. Brooks, T. Mimoni, and T. Eldar-Geva
Serum inhibin A, VEGF and TNF{alpha} levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial
Hum. Reprod., May 1, 2006; 21(5): 1260 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. Van Oosterom, and E. A. De Bruijn
Vascular Endothelial Growth Factor and Angiogenesis
Pharmacol. Rev., December 1, 2004; 56(4): 549 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T.A. Molskness, R.L. Stouffer, K.A. Burry, M.J. Gorrill, D.M. Lee, and P.E. Patton
Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women
Hum. Reprod., April 1, 2004; 19(4): 822 - 830.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Aboulghar, J.H. Evers, and H. Al-Inany
Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review
Hum. Reprod., December 1, 2002; 17(12): 3027 - 3032.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
C. Albert, N. Garrido, A. Mercader, C.V. Rao, J. Remohi, C. Simon, and A. Pellicer
The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome
Mol. Hum. Reprod., May 1, 2002; 8(5): 409 - 418.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Quintana, L. Kopcow, G. Marconi, C. Sueldo, G. Speranza, and R.I. Baranao
Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis
Hum. Reprod., September 1, 2001; 16(9): 1814 - 1818.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Neulen, D. Wenzel, C. Hornig, E. Wunsch, U. Weissenborn, K. Grunwald, R. Buttner, and H. Weich
Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols
Hum. Reprod., April 1, 2001; 16(4): 621 - 626.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. Jelkmann
Pitfalls in the Measurement of Circulating Vascular Endothelial Growth Factor
Clin. Chem., April 1, 2001; 47(4): 617 - 623.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C.-D. Chen, H.-F. Chen, H.-F. Lu, S.-U. Chen, H.-N. Ho, and Y.-S. Yang
Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome
Hum. Reprod., May 1, 2000; 15(5): 1037 - 1042.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.